You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
阿斯利康美国新冠疫苗测试仍未恢复
阿思达克 09-21 10:16
据《路透》报道,英国药厂阿斯利康(AstraZeneca)表示,与英国牛津大学研发的新冠疫苗在美国的测试仍未恢复,公司亦披露新冠疫苗测试的详情。美国食品及药物管理局(FDA)早前指,当局将与阿斯利康就新冠疫苗测试中有英国志愿者出现严重反应事件作非常详细的调查,以保障美国志愿者安全。

英国1名志愿者在注射测试疫苗後出现横贯性脊髓炎。阿斯利康在英国、巴西及南非的测试继续进行,惟在美国的测试暂停。

牛津大学称该宗个案或与志愿者本身问题有关,或与疫苗无关,并称在独立调查後,认为情况不大可能与疫苗有关,或没有足够证据证明与疫苗有关。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account